美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ocera Therapeutics, Inc.

1.79

0.0000

成交量：- -

成交額：- -

市值：4,745.29萬

市盈率：-1.70

高：1.79

開：1.79

低：1.79

收：1.79

52周最高：2.95

52周最低：0.5200

股本：2,651.00萬

流通股本：1,064.60萬

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-1.0500

淨資產收益率：--

總資產收益率：--

市淨率：5.12

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Ocera Therapeutics, Inc.

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.ocerainc.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Ocera Therapeutics, Inc.於1998年1月12日在特拉華州註冊成立。公司是一家致力於發現，開發和商業化機制的生物製藥公司。公司所有的候選產品都是通過使用其專有化學技術平台的科學家發現的，該技術平台被稱為MATCH，能夠以可預見和高效的方式建立類藥大環化合物的函數庫。公司擁有一流的候選產品和強大的藥物發現平台，並追求與有能力的公司合作以補充自己的方案。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/OCRX/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"OCRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OCRX\",,,,,undefined,":{"symbol":"OCRX","market":"US","secType":"STK","nameCN":"Ocera Therapeutics, Inc.","latestPrice":1.79,"timestamp":1512766800000,"preClose":1.79,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":10646000,"shares":26510000,"eps":-1.05,"marketStatus":"停牌","change":0,"latestTime":"03-18 09:48:57 EDT","open":1.79,"high":1.79,"low":1.79,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.05,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1773864000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1301889600000,"exchange":"NASDAQ","adjPreClose":1.79,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OCRX\",,,,,undefined,":{"symbol":"OCRX","floatShares":10646000,"roa":"--","roe":"--","lyrEps":0,"shares":26510000,"dividePrice":0,"high":1.79,"amplitude":0,"preClose":1.79,"low":1.79,"week52Low":0.52,"pbRate":"5.12","week52High":2.95,"institutionHeld":0,"latestPrice":1.79,"eps":-1.05,"divideRate":0,"volume":0,"delay":0,"ttmEps":-1.05,"open":1.79,"prevYearClose":1.79},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OCRX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2017-11-14","symbol":"OCRX","fiscalQuarterEnding":"2017/09","expectedEps":-0.24,"name":null,"time":"","type":"earning","dateTimestamp":1510635600000,"reportTimeType":"","actualEps":-0.24},{"market":"US","date":"2017-08-01","symbol":"OCRX","fiscalQuarterEnding":"2017/06","expectedEps":-0.23,"name":null,"time":"","type":"earning","dateTimestamp":1501560000000,"reportTimeType":"","actualEps":-0.23},{"market":"US","date":"2017-05-09","symbol":"OCRX","fiscalQuarterEnding":"2017/03","expectedEps":-0.24,"name":null,"time":"","type":"earning","dateTimestamp":1494302400000,"reportTimeType":"","actualEps":-0.28},{"market":"US","date":"2017-03-10","symbol":"OCRX","fiscalQuarterEnding":"2016/12","expectedEps":-0.34,"name":null,"time":"","type":"earning","dateTimestamp":1489122000000,"reportTimeType":"","actualEps":-0.22},{"market":"US","date":"2016-11-02","symbol":"OCRX","fiscalQuarterEnding":"2016/09","expectedEps":-0.36,"name":null,"time":"","type":"earning","dateTimestamp":1478059200000,"reportTimeType":"","actualEps":-0.32}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OCRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OCRX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.ocerainc.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0094},{"period":"1month","weight":-0.0161},{"period":"3month","weight":-0.0009},{"period":"6month","weight":0.0129},{"period":"1year","weight":0.1827},{"period":"ytd","weight":-0.0163}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Ocera Therapeutics, Inc.於1998年1月12日在特拉華州註冊成立。公司是一家致力於發現，開發和商業化機制的生物製藥公司。公司所有的候選產品都是通過使用其專有化學技術平台的科學家發現的，該技術平台被稱為MATCH，能夠以可預見和高效的方式建立類藥大環化合物的函數庫。公司擁有一流的候選產品和強大的藥物發現平台，並追求與有能力的公司合作以補充自己的方案。","exchange":"NASDAQ","name":"Ocera Therapeutics, Inc.","nameEN":"Ocera Therapeutics"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"OCRX\",market:\"US\",,,undefined,":null}}